Class information for:
Level 1: TUMOR VACCINE//GENE THERAPY//B71

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
8124 1289 43.0 86%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
10 3       IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL 134299
140 2             IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY 23462
8124 1                   TUMOR VACCINE//GENE THERAPY//B71 1289

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 TUMOR VACCINE authKW 175665 4% 14% 54
2 GENE THERAPY authKW 86840 18% 2% 230
3 B71 authKW 80045 1% 26% 13
4 CANCER GENE THERAPY journal 77352 6% 4% 80
5 INTERLEUKIN 2 authKW 74798 8% 3% 105
6 ALLOGENEIC VACCINATION authKW 71063 0% 100% 3
7 CYTOKINE GENE TRANSFER authKW 60904 0% 43% 6
8 GM CSF authKW 56567 5% 4% 66
9 ALLOGENEIC VACCINE authKW 53830 0% 45% 5
10 SHUNDE PEOPLES HOSP address 53295 0% 75% 3

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 10943 48% 0% 615
2 Medicine, Research & Experimental 8688 31% 0% 399
3 Immunology 4307 29% 0% 368
4 Biotechnology & Applied Microbiology 2510 20% 0% 253
5 Genetics & Heredity 2310 19% 0% 239
6 Hematology 110 4% 0% 47
7 Cell Biology 110 7% 0% 88
8 Surgery 22 5% 0% 60
9 Urology & Nephrology 20 2% 0% 25
10 Biochemistry & Molecular Biology 15 8% 0% 104

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 SHUNDE PEOPLES HOSP 53295 0% 75% 3
2 CLEMMA A HEWITT GENE THER Y 47375 0% 100% 2
3 CLIN COOPERAT GRP UROL TUMORS 47375 0% 100% 2
4 CLIN SCI K4 414 31582 0% 67% 2
5 GRP GENE THER Y TUMORS 31582 0% 67% 2
6 THER EUT VACCINES 31582 0% 67% 2
7 MICROBIOL IMMUNOL MC 790 31160 0% 26% 5
8 ADV CELL MOL THER Y 30452 0% 43% 3
9 UNIT GENE THER Y 30452 0% 43% 3
10 220 SANTA MONICA BLVD 23688 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CANCER GENE THERAPY 77352 6% 4% 80
2 JOURNAL OF IMMUNOTHERAPY 41010 4% 3% 54
3 HUMAN GENE THERAPY 37799 6% 2% 73
4 CANCER IMMUNOLOGY IMMUNOTHERAPY 18931 5% 1% 59
5 GENE THERAPY 8233 3% 1% 37
6 CYTOKINES AND MOLECULAR THERAPY 7011 0% 7% 4
7 NATURAL IMMUNITY 6123 0% 4% 6
8 FOLIA BIOLOGICA 4825 1% 1% 17
9 CYTOKINES CELLULAR & MOLECULAR THERAPY 3049 0% 3% 4
10 CURRENT OPINION IN MOLECULAR THERAPEUTICS 2180 1% 1% 9

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 TUMOR VACCINE 175665 4% 14% 54 Search TUMOR+VACCINE Search TUMOR+VACCINE
2 GENE THERAPY 86840 18% 2% 230 Search GENE+THERAPY Search GENE+THERAPY
3 B71 80045 1% 26% 13 Search B71 Search B71
4 INTERLEUKIN 2 74798 8% 3% 105 Search INTERLEUKIN+2 Search INTERLEUKIN+2
5 ALLOGENEIC VACCINATION 71063 0% 100% 3 Search ALLOGENEIC+VACCINATION Search ALLOGENEIC+VACCINATION
6 CYTOKINE GENE TRANSFER 60904 0% 43% 6 Search CYTOKINE+GENE+TRANSFER Search CYTOKINE+GENE+TRANSFER
7 GM CSF 56567 5% 4% 66 Search GM+CSF Search GM+CSF
8 ALLOGENEIC VACCINE 53830 0% 45% 5 Search ALLOGENEIC+VACCINE Search ALLOGENEIC+VACCINE
9 GENE MODIFIED TUMOR CELLS 47375 0% 100% 2 Search GENE+MODIFIED+TUMOR+CELLS Search GENE+MODIFIED+TUMOR+CELLS
10 B71 CD80 44873 0% 32% 6 Search B71+CD80 Search B71+CD80

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 PARDOLL, DM , (2000) THERAPEUTIC VACCINATION FOR CANCER.CLINICAL IMMUNOLOGY. VOL. 95. ISSUE 1. P. S44-S62 62 53% 33
2 BLANKENSTEIN, T , CAYEUX, S , QIN, ZH , (1996) GENETIC APPROACHES TO CANCER IMMUNOTHERAPY.REVIEWS OF PHYSIOLOGY, BIOCHEMISTRY AND PHARMACOLOGY. VOL. 129. ISSUE . P. 1-49 67 54% 12
3 NANNI, P , FORNI, G , LOLLINI, PL , (1999) CYTOKINE GENE THERAPY: HOPES AND PITFALLS.ANNALS OF ONCOLOGY. VOL. 10. ISSUE 3. P. 261 -266 47 59% 25
4 FORNI, G , CAVALLO, F , CONSALVO, M , ALLIONE, A , DELLABONA, P , CASORATI, G , GIOVARELLI, M , (1995) MOLECULAR APPROACHES TO CANCER IMMUNOTHERAPY.CYTOKINES AND MOLECULAR THERAPY. VOL. 1. ISSUE 4. P. 225-248 72 42% 25
5 BONNEKOH, B , BICKENBACH, JR , ROOP, DR , (1997) IMMUNOLOGICAL GENE THERAPY APPROACHES FOR MALIGNANT MELANOMA .2. PRECLINICAL STUDIES AND CLINICAL STRATEGIES.SKIN PHARMACOLOGY. VOL. 10. ISSUE 3. P. 105-125 46 62% 1
6 PARMIANI, G , PILLA, L , MACCALLI, C , RUSSO, V , (2011) AUTOLOGOUS VERSUS ALLOGENEIC CELL-BASED VACCINES?.CANCER JOURNAL. VOL. 17. ISSUE 5. P. 331 -336 34 54% 6
7 COLOMBO, MP , FORNI, G , (1994) CYTOKINE GENE-TRANSFER IN TUMOR-INHIBITION AND TUMOR-THERAPY - WHERE ARE WE NOW.IMMUNOLOGY TODAY. VOL. 15. ISSUE 2. P. 48-51 28 80% 234
8 ROCHLITZ, C , DRENO, B , JANTSCHEFF, P , CAVALLI, F , SQUIBAN, P , ACRES, B , BAUDIN, M , ESCUDIER, B , HEINZERLING, L , MORANT, R , ET AL (2002) IMMUNOTHERAPY OF METASTATIC MELANOMA BY INTRATUMORAL INJECTIONS OF VERO CELLS PRODUCING HUMAN IL-2: PHASE II RANDOMIZED STUDY COMPARING TWO DOSE LEVELS.CANCER GENE THERAPY. VOL. 9. ISSUE 3. P. 289-295 30 73% 23
9 ORCHARD, PJ , KATSANIS, E , BOYER, M , MAY, C , MCIVOR, RS , BLAZAR, BR , (1996) INTERLEUKIN-2 SECRETION BY TRANSDUCED AND UNSELECTED BDL-2 LYMPHOMA RESULTS IN INCREASED SURVIVAL IN MICE WITH PREVIOUSLY ESTABLISHED DISSEMINATED DISEASE.CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. VOL. 11. ISSUE 2. P. 155-164 31 82% 1
10 PAWELEC, G , REES, RC , KIESSLING, R , MADRIGAL, A , DODI, A , BAXEVANIS, C , GAMBACORTI-PASSERINI, C , MASUCCI, G , ZEUTHEN, J , (1999) CELLS AND CYTOKINES IN IMMUNOTHERAPY AND GENE THERAPY OF CANCER.CRITICAL REVIEWS IN ONCOGENESIS. VOL. 10. ISSUE 1-2. P. 83-127 89 24% 30

Classes with closest relation at Level 1


Rank Class id link
1 17208 NEWCASTLE DISEASE VIRUS//ACTIVE SPECIFIC IMMUNOTHERAPY ASI//ACTIVE SPECIFIC IMMUNOTHERAPY
2 7508 TUMOR INFILTRATING LYMPHOCYTES//ADOPTIVE IMMUNOTHERAPY//TIL
3 3940 SUICIDE GENE THERAPY//CYTOSINE DEAMINASE//HERPES SIMPLEX VIRUS THYMIDINE KINASE
4 5847 INTERLEUKIN 12//IL 12//IL 12 RECEPTOR
5 13629 TUMOR IMMUNOL BIOL//SIPULEUCEL T//5T4
6 24733 TUMOR IMMUN TOLERANCE SECT//SV40 T ANTIGEN TRANSGENIC MICE//CCDC134
7 25218 ORAL BIOL ORAL MED//CD3 ZETA//ZETA CHAIN
8 22094 SECT STUDIES HOST IMMUNE PONSE//GENE IMMUNE MED//CANC BIOL 173
9 1375 CANCER TESTIS ANTIGEN//NY ESO 1//MAGE
10 2395 CD28//COSTIMULATION//B7

Go to start page